241 related articles for article (PubMed ID: 15916986)
1. Phytoestrogens and prostate cancer risk.
Ganry O
Prev Med; 2005 Jul; 41(1):1-6. PubMed ID: 15916986
[TBL] [Abstract][Full Text] [Related]
2. Phytoestrogen intake and prostate cancer: a case-control study using a new database.
Strom SS; Yamamura Y; Duphorne CM; Spitz MR; Babaian RJ; Pillow PC; Hursting SD
Nutr Cancer; 1999; 33(1):20-5. PubMed ID: 10227039
[TBL] [Abstract][Full Text] [Related]
3. Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer.
Hedelin M; Bälter KA; Chang ET; Bellocco R; Klint A; Johansson JE; Wiklund F; Thellenberg-Karlsson C; Adami HO; Grönberg H
Prostate; 2006 Oct; 66(14):1512-20. PubMed ID: 16921512
[TBL] [Abstract][Full Text] [Related]
4. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden).
Hedelin M; Klint A; Chang ET; Bellocco R; Johansson JE; Andersson SO; Heinonen SM; Adlercreutz H; Adami HO; Grönberg H; Bälter KA
Cancer Causes Control; 2006 Mar; 17(2):169-80. PubMed ID: 16425095
[TBL] [Abstract][Full Text] [Related]
5. Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know.
Velentzis LS; Woodside JV; Cantwell MM; Leathem AJ; Keshtgar MR
Eur J Cancer; 2008 Sep; 44(13):1799-806. PubMed ID: 18614351
[TBL] [Abstract][Full Text] [Related]
6. Phyto-oestrogens and risk of prostate cancer in Scottish men.
Heald CL; Ritchie MR; Bolton-Smith C; Morton MS; Alexander FE
Br J Nutr; 2007 Aug; 98(2):388-96. PubMed ID: 17403269
[TBL] [Abstract][Full Text] [Related]
7. [Phytoestrogen and cancer prevention].
Watanabe S; Uesugi S; Zhuo X; Kimira M
Gan To Kagaku Ryoho; 2003 Jul; 30(7):902-8. PubMed ID: 12894701
[TBL] [Abstract][Full Text] [Related]
8. Phytoestrogens and breast cancer risk. Review of the epidemiological evidence.
Peeters PH; Keinan-Boker L; van der Schouw YT; Grobbee DE
Breast Cancer Res Treat; 2003 Jan; 77(2):171-83. PubMed ID: 12602916
[TBL] [Abstract][Full Text] [Related]
9. Soy consumption and phytoestrogens: effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic men.
Jenkins DJ; Kendall CW; D'Costa MA; Jackson CJ; Vidgen E; Singer W; Silverman JA; Koumbridis G; Honey J; Rao AV; Fleshner N; Klotz L
J Urol; 2003 Feb; 169(2):507-11. PubMed ID: 12544298
[TBL] [Abstract][Full Text] [Related]
10. Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men.
Maskarinec G; Morimoto Y; Hebshi S; Sharma S; Franke AA; Stanczyk FZ
Eur J Clin Nutr; 2006 Dec; 60(12):1423-9. PubMed ID: 16775579
[TBL] [Abstract][Full Text] [Related]
11. Soy, disease prevention, and prostate cancer.
Moyad MA
Semin Urol Oncol; 1999 May; 17(2):97-102. PubMed ID: 10332923
[TBL] [Abstract][Full Text] [Related]
12. Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementation.
Rannikko A; Petas A; Rannikko S; Adlercreutz H
Prostate; 2006 Jan; 66(1):82-7. PubMed ID: 16114063
[TBL] [Abstract][Full Text] [Related]
13. Phytoestrogens and thyroid cancer risk: the San Francisco Bay Area thyroid cancer study.
Horn-Ross PL; Hoggatt KJ; Lee MM
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):43-9. PubMed ID: 11815400
[TBL] [Abstract][Full Text] [Related]
14. Urinary phytoestrogens and risk of prostate cancer in Jamaican men.
Jackson MD; McFarlane-Anderson ND; Simon GA; Bennett FI; Walker SP
Cancer Causes Control; 2010 Dec; 21(12):2249-57. PubMed ID: 20924663
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai.
Dai Q; Franke AA; Jin F; Shu XO; Hebert JR; Custer LJ; Cheng J; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):815-21. PubMed ID: 12223424
[TBL] [Abstract][Full Text] [Related]
16. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer.
Magee PJ; Rowland IR
Br J Nutr; 2004 Apr; 91(4):513-31. PubMed ID: 15035679
[TBL] [Abstract][Full Text] [Related]
17. Enterolactone as a risk factor for breast cancer: a review of the published evidence.
Boccardo F; Puntoni M; Guglielmini P; Rubagotti A
Clin Chim Acta; 2006 Mar; 365(1-2):58-67. PubMed ID: 16168401
[TBL] [Abstract][Full Text] [Related]
18. Phytoestrogens: potential benefits and implications for breast cancer survivors.
Duffy C; Cyr M
J Womens Health (Larchmt); 2003 Sep; 12(7):617-31. PubMed ID: 14583103
[TBL] [Abstract][Full Text] [Related]
19. Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada).
Cotterchio M; Boucher BA; Kreiger N; Mills CA; Thompson LU
Cancer Causes Control; 2008 Apr; 19(3):259-72. PubMed ID: 17992574
[TBL] [Abstract][Full Text] [Related]
20. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men.
Kurahashi N; Iwasaki M; Sasazuki S; Otani T; Inoue M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):538-45. PubMed ID: 17337648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
